Ratiopharm
Ratiopharm is a German pharmaceutical company that is Europe's leading generics brand.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Desloratadine ratiopharm | Desloratadine | 2012-01-13 | ||
| Eporatio | Epoetin theta | 2009-10-29 | ||
| Filgrastim ratiopharm | Filgrastim | 2008-09-15 | ||
| Leflunomide ratiopharm | Leflunomide | 2010-11-28 | ||
| Levetiracetam ratiopharm | Levetiracetam | 2011-08-26 | 2026-2034 | |
| Memantine ratiopharm | Memantine | 2013-06-12 | 2025-2029 | |
| Pazenir | Paclitaxel | 2019-05-06 | 2024-2034 | |
| Ratiograstim | Filgrastim | 2008-09-15 | ||
| Risperidone | Risperidone | 2010-06-08 | 2025-2033 | |
| Sildenafil ratiopharm | Sildenafil | 2009-12-23 | 2038 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use